Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2

Background The dedifferentiated variant of chondrosarcoma is highly aggressive and carries an especially grim prognosis. While chemotherapeutics has failed to benefit patients with dedifferentiated chondrosarcoma significantly, preclinical chemosensitivity studies have been limited by a scarcity of...

Full description

Bibliographic Details
Main Authors: Xiaoyang Li, Dylan C. Dean, Al Ferreira, Scott D. Nelson, Francis J. Hornicek, Shengji Yu, Zhenfeng Duan
Format: Article
Language:English
Published: SAGE Publishing 2021-11-01
Series:Cancer Control
Online Access:https://doi.org/10.1177/10732748211045274